Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check10 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check17 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check54 days agoChange DetectedThe web page has been updated to reflect a new version of a clinical trial for advanced hepatocellular carcinoma (HCC), specifically detailing the randomization of subjects and the treatment arms involved. The previous detailed descriptions of the study's objectives and inclusion/exclusion criteria have been removed.SummaryDifference11%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.